TABLE 3.
Distribution of pain and numbness at follow-up
| Visit (days) | 10 | 42 | 180 | 365 |
| Total number analyzed | 18 | 20 | 22 | 23 |
| Pain | ||||
| None | 15 (83.3%) | 18 (90.0%) | 18 (81.8%) | 23 (100%) |
| Limited (VAS 1–3) | 3 (16.7%) | 2 (10%) | 3 (13.6%) | 0 |
| Moderate (VAS 4–7) | 0 | 0 | 1 (4.5%) | 0 |
| Extensive (VAS 8–10) | 0 | 0 | 0 | 0 |
| Total number analyzed | 18 | 20 | 22 | 22 |
| Numbness score | ||||
| None | 18 (100%) | 18 (90%) | 22 (100%) | 22 (100%) |
| Limited (VAS 1–3) | 0 | 2 (10%) | 0 | 0 |
| Moderate (VAS 4–7) | 0 | 0 | 0 | 0 |
| Extensive (VAS 8–10) | 0 | 0 | 0 | 0 |
Numbers in parentheses are percentages of the total number analyzed.